Cargando…
Lassa virus diversity and feasibility for universal prophylactic vaccine
Lassa virus (LASV) is a highly prevalent mammarenavirus in West Africa and is maintained in nature in a persistently infected rodent host, Mastomys natalensis, which is widely spread in sub-Saharan Africa. LASV infection of humans can cause Lassa fever (LF), a disease associated with high morbidity...
Autores principales: | Lukashevich, Igor S., Paessler, Slobodan, de la Torre, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357994/ https://www.ncbi.nlm.nih.gov/pubmed/30774934 http://dx.doi.org/10.12688/f1000research.16989.1 |
Ejemplares similares
-
Advanced Vaccine Candidates for Lassa Fever
por: Lukashevich, Igor S.
Publicado: (2012) -
Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation
por: Johnson, Dylan M., et al.
Publicado: (2021) -
Animal Models of Lassa Fever
por: Sattler, Rachel A., et al.
Publicado: (2020) -
Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1(-/-) Mice
por: Johnson, Dylan M., et al.
Publicado: (2019) -
Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage
por: Manning, John T., et al.
Publicado: (2015)